425: Strive CFO Updates on Semler Scientific Merger via X.com

Strive's CFO posted on X.com regarding the proposed business combination with Semler Scientific, emphasizing the ongoing process and regulatory filings.

Summary

• Strive, Inc.'s Chief Financial Officer, Ben Pham, posted a communication on X.com on September 22, 2025, concerning the proposed business combination with Semler Scientific, Inc.
• The communication serves as a Rule 425 filing, providing information related to the merger.
• It includes a cautionary statement regarding forward-looking statements, outlining inherent risks and uncertainties associated with the transaction.
• Strive intends to file a Registration Statement on Form S-4, which will include an Information Statement/Proxy Statement/Prospectus, with the SEC.
• The definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read all relevant SEC filings when they become available for important information about both companies and the proposed transaction.
• The filing identifies Strive, Semler Scientific, and certain of their directors, executive officers, and employees as potential participants in the solicitation of proxies.
• It clarifies that the communication does not constitute an offer to sell securities or a solicitation of votes.

Sentiment

Score: 5

Explanation: The filing is neutral in tone, primarily serving as a procedural update and a comprehensive disclosure of forward-looking statements and associated risks regarding a proposed business combination. It does not present new financial results or operational achievements, but rather outlines the process and potential challenges.

Positives

• Anticipated strategic benefits of the proposed transaction are expected.
• Anticipated financial benefits of the proposed transaction are expected.
• The proposed transaction is expected to have a positive impact on the combined company's future financial performance.

Negatives

• The proposed transaction may not close when expected or at all due to unfulfilled conditions.
• Anticipated benefits, including cost savings and strategic gains, may not be realized.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Dilution will be caused by Strive's issuance of additional shares of its Class A common stock.
• Potential adverse reactions from customers or changes to business or employee relationships may occur.
• Changes in Strive's or Semler Scientific's share price may occur before closing.

Risks

• The occurrence of any event, change, or circumstance could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized, potentially due to changes in Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact the transaction.
• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors, including unknown or unpredictable factors, could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The outlook includes expectations for the proposed transaction, anticipated strategic and financial benefits, the expected impact on the combined company's future financial performance, the timing of the closing, and the ability to successfully integrate the combined businesses. These statements are subject to significant risks and uncertainties.

Management Comments

• Ben Pham, Chief Financial Officer of Strive, Inc., posted the communication on X.com on September 22, 2025, regarding the proposed business combination with Semler Scientific, Inc.

Industry Context

The filing highlights risks associated with Bitcoin and other digital assets, and the implementation of Bitcoin treasury strategies, suggesting that the combined entity may be adopting or expanding its involvement in this area, a trend observed in some companies seeking alternative treasury management or investment strategies.

Corporate Governance

Related Party Transactions

• Semler Scientific's transactions with related persons are referenced as being set forth in the 'TRANSACTIONS WITH RELATED PERSONS' section of its definitive proxy statement in connection with its 2025 Annual Meeting of Stockholders.

Stakeholder Impact

• Shareholders of Strive: Potential dilution due to the issuance of additional Class A common stock.
• Shareholders of Semler Scientific: Required to approve the proposed transaction through proxy solicitation.
• Customers: Potential for adverse reactions or changes to business relationships due to the merger announcement or completion.
• Employees: Potential for changes to employee relationships due to the merger announcement or completion.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement of Strive, proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Recommendation

The filing is a procedural update regarding a proposed business combination between Strive and Semler Scientific, primarily detailing regulatory steps and comprehensive risk factors. It does not provide new financial performance data or operational achievements. While the merger has anticipated strategic and financial benefits, the extensive list of risks, including potential for non-closure, integration difficulties, and dilution, warrants a cautious 'hold' stance. Investors should await the definitive Information Statement/Proxy Statement/Prospectus and further developments before making significant investment decisions.

Keywords

Strive Inc., Semler Scientific Inc., Merger, Acquisition, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Corporate Governance, Bitcoin Treasury Strategy, Digital Assets, Proxy Solicitation